Sarpagandha ghanvati will be given to patients of High blood pressure
- Conditions
- Essential (primary) hypertension. Ayurveda Condition: RAKTAVRUTAVATAH,
- Registration Number
- CTRI/2023/07/055053
- Lead Sponsor
- MANISHA
- Brief Summary
This study is a open label clinical trial to determine the efficacy of sarpagandha ghanvati in hypertension for the age group between 18 to 70 years for 45 days.Study will be conducted at UAU, Gurukul Campus, Haridwar on 40 patients. Assessment will be done on the basis of subjective and objective parameters. Study will be conducted at OPD/IPD level of PG department of Kayachikitsa. Assessment will be done at weekly interval and result obtained will be analyzed using appropriate tests
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 40
Patients of either sex with age between 18-70 years Patients having Systolic Blood Pressure is more than 140 and less than 180 mm of Hg Patients having Diastolic Blood Pressure is more than 90 and less than or equal to 110 mm of Hg.
Patients of either sex below 18 years & above 70 years will be excluded from the study Patients having Systolic Blood Pressure is more than 180mm of Hg Patients having Diastolic Blood Pressure is more than 110mmHg Patients suffering from serious comorbidities like Renal failure, Coronaryartery disease, endocrinal disorder, congestive heart disease Pregnant woman.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method a) Headache Assessment willl be done weekly for 8 weeks b) Giddiness Assessment willl be done weekly for 8 weeks c) Palpitations Assessment willl be done weekly for 8 weeks d) Breathlessness Assessment willl be done weekly for 8 weeks e) Insomnia Assessment willl be done weekly for 8 weeks
- Secondary Outcome Measures
Name Time Method 1. systolic blood pressure 2. diastolic blood pressure
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
UAU,GURUKUL CAMPUS HARIDWAR
🇮🇳Hardwar, UTTARANCHAL, India
UAU,GURUKUL CAMPUS HARIDWAR🇮🇳Hardwar, UTTARANCHAL, IndiaDr MANISHAPrincipal investigator8546890482manisha1995tamta@gmail.com